Journal article
Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
Cecilie Kyro, Raul Zamora-Ros, Augustin Scalbert, Anne Tjonneland, Laure Dossus, Christoffer Johansen, Pernille Envold Bidstrup, Elisabete Weiderpass, Jane Christensen, Heather Ward, Dagfinn Aune, Elio Riboli, Mathilde His, Francoise Clavel-Chapelon, Laura Baglietto, Verena Katzke, Tilman Kuehn, Heiner Boeing, Anna Floegel, Kim Overvad Show all
Breast Cancer Research and Treatment | SPRINGER | Published : 2015
Grants
Awarded by Innovation Fund Denmark
Awarded by Health Research Fund, Regional Governments of Andalucia, Asturias, Basque Country, Murcia
Awarded by Navarra, RETIC (Spain)
Awarded by Cancer Research UK
Awarded by Medical Research Council
Awarded by National Institute for Health Research
Awarded by The Danish Cancer Society
Funding Acknowledgements
This work was funded by Innovation Fund Denmark (ELIN: 0603-00580B). The coordination of EPIC is financially supported by the European Commission (DG-SANCO) and the International Agency for Research on Cancer. The national cohorts are supported by Danish Cancer Society (Denmark); Ligue Contre le Cancer, Institut Gustave Roussy, Mutuelle Generale de l'Education Nationale, Institut National de la Sante et de la Recherche Medicale (France); German Cancer Aid, German Cancer Research Center, Federal Ministry of Education and Research (Germany); the Hellenic Health Foundation (Greece); Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy, and National Research Council (Italy); Dutch Ministry of Public Health, Welfare and Sports, Netherlands Cancer Registry, LK Research Funds, Dutch Prevention Funds, Dutch Zorg Onderzoek Nederland, World Cancer Research Fund, Statistics Netherlands (The Netherlands); ERC-2009-AdG 232997, the Norwegian Research Council, Extrastiftelsen Helse og Rehabiliering med Extra-midler (Norway); Health Research Fund, Regional Governments of Andalucia, Asturias, Basque Country, Murcia (no. 6236) and Navarra, RETIC (RD06/0020/0091 and RD12/0036/0018) (Spain); Swedish Cancer Society, Swedish Scientific Council and Regional Government of Skane and Vasterbotten (Sweden); and Cancer Research UK, Medical Research Council (UK).